Related Experiment Video
Updated: Jul 19, 2026

Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
Hormone therapy: physiological complexity belies therapeutic simplicity
Judith L Turgeon1, Donald P McDonnell, Kathryn A Martin
1Department of Internal Medicine, Division of Endocrinology, Clinical Nutrition, and Vascular Medicine, University of California-Davis, Davis, CA 95616, USA. jlturgeon@ucdavis.edu
Abstract:
The results of the Women's Health Initiative, a study anticipated to provide definitive answers about health benefits and risks of postmenopausal hormone therapy, have generated debate and confusion among clinicians, researchers, and the lay public. The ovarian hormones estrogen and progesterone, which decline at menopause, normally elicit complex tissue-specific responses throughout the body. Major advances are providing a detailed molecular definition of how that differential action is achieved. Here we review estrogen and progestin actions, discuss how effectively knowledge of steroid hormone endocrinology has been incorporated into clinical studies, and consider the impact on modern hormone therapy protocols and pharmaceutical development.
Insights
Postmenopausal hormone therapy (HT) results are debated. Understanding estrogen and progestin actions at a molecular level is key for refining HT protocols and drug development.
Area of Science:
- Endocrinology and Molecular Biology
- Reproductive Health
Background:
- The Women's Health Initiative study aimed to clarify postmenopausal hormone therapy (HT) risks and benefits.
- Study results generated significant debate and confusion among healthcare professionals and the public.
- Menopause involves a decline in ovarian hormones (estrogen and progesterone), affecting various bodily tissues.
Purpose of the Study:
- To review the tissue-specific actions of estrogen and progestin.
- To assess the integration of steroid hormone endocrinology knowledge into clinical studies.
- To consider the impact on current hormone therapy protocols and pharmaceutical advancements.
Main Methods:
- Review of current scientific literature on estrogen and progestin actions.
- Analysis of how molecular endocrinology insights inform clinical trial design.
- Evaluation of the influence on contemporary hormone therapy strategies.
Main Results:
- Advances in molecular biology are defining the differential actions of steroid hormones.
- Understanding these molecular mechanisms is crucial for interpreting clinical findings.
- Existing knowledge of endocrinology has been variably incorporated into clinical studies.
Conclusions:
- A deeper molecular understanding of estrogen and progestin is essential for resolving HT controversies.
- Improved integration of endocrinology research can optimize hormone therapy protocols.
- This knowledge is vital for future pharmaceutical development in women's health.
More Related Videos
Related Concept Videos
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Dose-Response Relationship: Selectivity and Specificity
Antidepressant Drugs: MAOIs and Other Agents
Pharmacokinetic–Pharmacodynamic Relationship: Problems
Pharmaceutical Poisoning: Treatment Strategies
Acne Infection

